Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2020

View Archived Issues

MARCH1 regulates IFN-I response and adaptive immunity in malaria parasite infections in mice

Notch4 key to asthma's T-cell derailment

A tense defense

New phase I trial evaluates Apomab theranostic for lung and ovarian cancer

Bristol-Myers Squibb presents new MGAT2 inhibitors

TRACON presents data for envafolimab in MSI-H/dMMR colorectal cancer

REVOLUTION Medicines patents SOS1 inhibitors

Eli Lilly initiates phase II study of LY-3041658 in hidradenitis suppurativa

Ensysce Biosciences discloses new compounds for ADHD

Silverback Therapeutics identifies TGFBR inhibitors

New compounds for cancer presented by Virginia Commonwealth University

Phase Ib data for DNL-201 in patients with PD with and without LRRK2 mutations

Metastatic migration is collective effort for colorectal cancers

Discovery of novel selective HDAC6-selective inhibitor, PTG-0861

AV-101 reverses L-Dopa-induced dyskinesia in parkinsonian monkeys

New phase II study evaluates encaleret for autosomal dominant hypocalcemia type 1

HanX begins phase I trial in China with ON-123300

FDA clears IND for study of inhaled Ampion in COVID-19 patients with respiratory distress

Biallelic loss of CFAP58 causes flagellar axoneme and asthenoteratozoospermia

ARCA submits IND for phase IIb/III evaluation of AB-201 for COVID-19

Blueprint reports data from EXPLORER and PATHFINDER trials of Ayvakit in systemic mastocytosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...